ADVANEM Trademark

Trademark Overview

On Friday, April 10, 2020, a trademark application was filed for ADVANEM with the United States Patent and Trademark Office. The USPTO has given the ADVANEM trademark a serial number of 88866929. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 17, 2022. This trademark is owned by Bayer Aktiengesellschaft. The ADVANEM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, anti-infectives
advanem

General Information

Serial Number88866929
Word MarkADVANEM
Filing DateFriday, April 10, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 17, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Goods and ServicesPharmaceuticals, namely, anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE

Trademark Events

Event DateEvent Description
Monday, October 17, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 17, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 10, 2022SOU EXTENSION 3 GRANTED
Thursday, March 10, 2022SOU EXTENSION 3 FILED
Thursday, March 10, 2022TEAS EXTENSION RECEIVED
Tuesday, September 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 3, 2021SOU EXTENSION 2 GRANTED
Friday, September 3, 2021SOU EXTENSION 2 FILED
Friday, September 3, 2021TEAS EXTENSION RECEIVED
Tuesday, February 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 29, 2021SOU EXTENSION 1 GRANTED
Friday, January 29, 2021SOU EXTENSION 1 FILED
Friday, January 29, 2021TEAS EXTENSION RECEIVED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 12, 2020ASSIGNED TO EXAMINER
Saturday, April 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 14, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

advanem infectives anti namely pharmaceuticals